Risk factors linked to postoperative morbidity in patients with hepatocellular carcinoma

British Journal of Surgery

Volumn 85, Issue 2, 1998, Pages 195-198

  Shimada, M ^a   Takenaka, K ^a   Fujiwara, Y ^a   Gion, T ^a   Shirabe, K ^a   Yanaga, K ^a   Sugimachi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; CANCER SURGERY; DIABETES MELLITUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; INTRAOPERATIVE PERIOD; LIVER CIRRHOSIS; LIVER NEOPLASMS; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0031951589     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1998.00567.x     Document Type: Article

References (23)

1. Yamanaka N, Okamoto E, Kuwata K, Tanaka N. A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 1984; 200: 658-63.
2. Ekberg H, Tranberg KG, Andersson R, Jeppsson B, Bengmark S. Major liver resection: perioperative course and management. Surgery 1986; 100: 1-8.
3. Nagasue N, Kohno H, Chang YC et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993; 217: 375-84.
4. Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74: 2772-80.
5. Yamanaka N, Okamoto E, Oriyama T et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 1994; 219: 342-6.
6. Fan ST, Lai ECS, Lo CM, Ng IOL, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995; 130: 198-203.
7. Lai ECS, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995; 221: 291-8.
8. Takenaka K, Kawahara N, Yamamoto K et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131: 71-6.
9. Shimada M, Matsumata T, Taketomi A, Shirabe K, Itasaka H, Sugimachi K et al. A new approach for liver surgery. Transdiaphragmatic hepatectomy for cirrhotic patients with hepatocellular carcinoma. Arch Surg 1995; 130: 157-60.
10. Couinaud C. Lobes et segments hepatiques; notes sur l'architecture anatomique et chirurgicale du foie. Presse Med 1954; 62: 709-12.
11. Shimada M, Matsumata T, Akazawa K, Kamakura T, Itasaka H, Sugimachi K et al. Estimation of risk of major complications after hepatic resection. Am J Surg 1994; 167: 399-403.
12. Matsumata T, Higashi H, Shimada M, Adachi E, Shirabe K, Sugimachi K. Indications for major hepatectomy in cirrhotic liver. Hepatogastroenterology 1994; 41: 165-9.
13. Ozawa K. Hepatic function and liver resection. J Gastroenterol Hepatol 1990; 5: 296-309.
14. Takenaka K, Kanematsu T, Sugimachi K, Inokuchi K. Serum lecithin cholesterol acyltransferase (LCAT) activity is an accurate predictor of post-operative hepatic failure. Dis Markers 1984; 2: 501-7.
15. Shimada M, Yanaga K, Makowka L, Kakizoe S, Van Thiel DH, Starzl TE. Significance of lecithin:cholesterol acyltransferase activity as a prognostic indicator of early allograft function in clinical liver transplantation. Transplantation 1989; 48: 600-3.
16. Shimada M, Yanaga K, Higashi H, Makowka L, Kakizoe S. Starzl TE. Pretransplant assessment of human liver grafts by plasma lecithin:cholesterol acyltransferase (LCAT) activity in multiple organ donors. Transpl Int 1992; 5: 27-30.
17. Takenaka K, Shimada M, Higashi H, Adachi E, Nishizaki T, Yanaga K et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg 1994; 129: 846-50.
18. Johnston DG, Johnson GA, Alberti KG, Millward Sadler GH, Mitchell J, Wright R. Hepatic regeneration and metabolism after partial hepatectomy in diabetic rats: effects of insulin therapy. Eur J Clin Invest 1986; 16: 384-90.
19. Stimpson RE, Pellegrini CA, Way LW. Factors affecting the morbidity of elective liver resection. Am J Surg 1987; 153: 189-96.
20. Yanaga K, Matsumata T, Hayashi H, Shimada M, Urata K, Suehiro T et al. Effect of diabetes mellitus on hepatic resection. Arch Surg 1993; 128: 445-8.
21. 2 synthetase inhibitor, OKY-046, reduces liver damage in hepatectomy. Surgery 1993; 114: 993-5 (Letter).
22. Shimada M, Matsumata T, Shirabe K, Kamakura T, Sugimachi K. Effect of nafamostat mesilate on coagulation and fibrinolysis in hepatic resection. J Am Coll Surg 1994; 178: 498-502.
23. Shimada M, Matsumata T, Taketomi A, Shirabe K, Yamamoto K, Sugimachi K. The role of prostaglandins in hepatic resection. Prostaglandins Leukot Essent Fatty Acids 1994; 50: 65-8.